| ADNP | activity-dependent neurotrophic protein |
| Aβ | β-amyloid peptide |
| AD | Alzheimer´s disease |
| AIS | acute ischemic stroke |
| APP | Alzheimer Aβ precursor protein |
| ASC | adipose tissue-derived mesenchymal stem cells |
| ASC-CCM | concentrated conditioned medium from ASC |
| ASC-CM | conditioned medium from ASC |
| ASC-EV | extracellular vesicles from ASC |
| BDNF | brain-derived neurotrophic factor |
| BM-MSC | bone marrow-derived MSC |
| CM | conditioned medium |
| CMS | chronic mild stress |
| CNS | central nervous system |
| EAE | experimental autoimmune encephalomyelitis |
| EMA | European Medicines Agency |
| EV | extracellular vesicles |
| FGF-2 | fibroblast-growth factor-2 |
| GCI | global cerebral ischemia |
| GMP | good manufacturing practices |
| HLA | human leucocyte antigen |
| HO-1 | heme oxygenase-1 |
| IFN-γ | interferon-γ |
| IL | Interleukin |
| iNOS | inducible nitric oxide synthase |
| LPS | lipopolysaccharide |
| MS | multiple sclerosis |
| MSC | mesenchymal stem cells |
| mTBI | mild traumatic brain injury |
| NK | natural killer cells |
| NO | nitric oxide |
| PD | Parkinson´s disease |
| PS1 | Presilin1 |
| PI3K | phosphoinositol-3-kinase |
| PKB | protein kinase B/Akt |
| PIP3 | phophoinositol-3-phosphate |
| SCI | spinal cord injury |
| SN | substantia nigra |
| TBI | traumatic brain injury |
| TH | tyrosine hydroxylase |
| TMEV | MS model of Theiler’s murine encephalomyelitis virus |
| TNF-α | tumor necrosis factor-α |
| RhoGEF | Rho guanine nucleotide exchange factor |
| VIP | vasoactive intestinal peptide |